Viva Biotech Holdings (1873.HK) released earnings for its full year that Increases, from the same period last year
The company's bottom line totaled RMB219.76 million, or RMB0.09 per share. This compares with RMB167.29 million, or RMB0.06 per share, last year.
Excluding items, Viva Biotech Holdings reported adjusted earnings of RMB335.30 million or RMB0.12 per share for the period.
The company's revenue for the period fell 12.9% to RMB1.730 billion from RMB1.987 billion last year.
Viva Biotech Holdings earnings at a glance (GAAP) :
-Earnings: RMB219.76 Mln. vs. RMB167.29 Mln. last year.-EPS: RMB0.09 vs. RMB0.06 last year.-Revenue: RMB1.730 Bln vs. RMB1.987 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.